Šalis: Airija
kalba: anglų
Šaltinis: HPRA (Health Products Regulatory Authority)
POTASSIUM IODATE
Alliance Pharmaceuticals Ltd.
POTASSIUM IODATE
85 Milligram
Tablets
Product not subject to medical prescription
Withdrawn
2014-03-12
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Potassium Iodate 85mg Tablets. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 85mg Potassium Iodate, equivalent to 50mg of Iodine. For a full list of excipients, see Section 6.1. 3 PHARMACEUTICAL FORM Tablet. Off white, round tablet with star shaped double break line, engraved 2202 on the obverse. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Potassium Iodate is indicated as a thyroid blocking agent to prevent the uptake of radioactive iodine following a nuclear accident. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION For oral administration. Administration should take place within 3 hours of a nuclear accident or up to 10 hours after an accident, however, this is less effective. A single daily dose should be administered. Repeated daily administration is necessary in situations involving prolonged exposure. However, pregnant and lactating women should ordinarily receive not more than two doses and neonates not more than one dose. Tablets Iodine equivalent ADULTS 2 tablets 100 mg AND ADOLESCENTS (over 12 years) CHILDREN 1 tablet 50 mg (3-12 years) CHILDREN ½ tablet 25 mg (1 month – 3 years) NEONATES ¼ tablet 12.5mg (birth – 1 month) or 12.5mg iodine equivalent as standard solution For neonates over 1 week of age living at home, a dosage of a ¼ tablet is satisfactory. For neonates less than one week of age a more exact dosage of 12.5 mg iodine equivalent should be given as a standard solution freshly prepared from KI crystals. It is recommended that maternity wards store KI crystals. For children the tablet dose may be crushed and mixed with mild or water before administration. IRISH MEDICINES BOARD __________________________________________________________________________________________________________ Perskaitykite visą dokumentą